Health Care & Life Sciences » Pharmaceuticals | Inspyr Therapeutics Inc.

Inspyr Therapeutics Inc.

Inspyr Therapeutics Inc.
Stock Exchange Other OTC
EPS
$0.67
Market Cap
$598.5 K
Shares Outstanding
150 M
Public Float
9.17 M

Profile

Address
31200 Via Colinas
Westlake Village California 91362
United States
Employees -
Website http://www.inspyrtx.com
Updated 07/08/2019
Inspyr Therapeutics, Inc. is a pharmaceutical company, which focuses on the development of prodrug cancer therapeutics for the treatment of solid tumors. The company's prodrug is an inactive precursor of a drug that is converted into its active form only at the site of the tumor. Its technology platform combines a powerful cytotoxin with a patented prodrug delivery system that targets the release of the drug within the tumor.

Financials

View All

Christopher P. Lowe
President, CEO, CFO, CAO & Executive Director
John Robison Montgomery
Director